Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee 2022-09-23 12:30
Shandong Proton Center Celebrates Milestone in Delivering High-Quality Proton Treatment 2022-09-23 08:00
WINNERS OF THE 2023 BREAKTHROUGH PRIZES IN LIFE SCIENCES, MATHEMATICS AND FUNDAMENTAL PHYSICS ANNOUNCED 2022-09-22 21:25
Agilis Robotics Targeting its Pre-B Round Fund-raising to be Completed by 2022 2022-09-22 14:31
China CDE Grants CMG901 Breakthrough Therapy Designation for Claudin 18.2-Positive Advanced Gastric & Gastroesophageal Junction Cancer 2022-09-22 13:05
RVAC Medicines Initiates First-in-Human Clinical Trials for mRNA COVID-19 Vaccine Candidates 2022-09-22 10:00
Ascentage Pharma Announces Phase I/II Data of Olverembatinib (HQP1351) Published in the Journal of Hematology & Oncology, Further Validating the Drug's Best-in-Class Potential 2022-09-21 22:49
Lunit Showcases AI Solutions for Radiology at AOCR & KCR 2022 2022-09-21 22:48
United Imaging and Carrollton Regional Medical Center Accelerate Installation of the Revolutionary uCT® ATLAS Scanner 2022-09-21 21:00
Heads of State Commit to Noncommunicable Disease Global Compact to Save 50 Million Lives by 2030 2022-09-21 20:12
Charsire's New Drug Aims to Capture Multi-Billion-Dollar Dementia Treatment Market 2022-09-21 20:00
JDRF Announces Launch of Global Type 1 Diabetes Index 2022-09-21 19:55
MGC Pharmaceuticals Successfully Developed Herbal-inspired Products for Treatment of Long COVID and COVID-19 2022-09-21 17:13
Mediaseek's Proprietary Neurofeedback Engine "Alpha Switch" and Its Smartphone Application Mentioned in International Journal 2022-09-21 14:00
Love Your Heart event to offer tips on overall and heart health 2022-09-21 13:00
Final IPAX-1 Study Data Confirms Safety and Tolerability Profile for TLX101, Preliminary Efficacy Data 2022-09-21 07:51
GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming 2022-09-21 05:39
Glyscend Therapeutics Releases New Phase 1 Biomarker Results and Initiates Phase 2 Clinical Trial under an IND for GLY-200 as a Potential First-in-Class Type 2 Diabetes Treatment 2022-09-21 05:33
Sirnaomics to Present Latest Developments on siRNA Therapeutics for Cancer and GalAhead(TM) Platform Programs at the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference 2022-09-20 22:40
Pulnovo Medical Released Results From PADN-CFDA Pivotal Trial For The Treatment Of Pulmonary Arterial Hypertension (PAH) 2022-09-20 20:30
1 207 208 209 210 211 895